APA (7th ed.) Citation

Z, H., M, Z., L, T., J, Z., F, Y., H, H., . . . H, H. (2026). Population Pharmacokinetic/Pharmacodynamic Modeling of Volagidemab, a Glucagon Receptor Antagonist, in Healthy Chinese and US Subjects Following Single Subcutaneous Administration. Pharmaceutical research, 43(4), 1057. https://doi.org/10.1007/s11095-026-04028-0

Chicago Style (17th ed.) Citation

Z, Hu, Zhu M, Tang L, Zhu J, Yu F, Huang H, Yan H, Xu R, and He H. "Population Pharmacokinetic/Pharmacodynamic Modeling of Volagidemab, a Glucagon Receptor Antagonist, in Healthy Chinese and US Subjects Following Single Subcutaneous Administration." Pharmaceutical Research 43, no. 4 (2026): 1057. https://doi.org/10.1007/s11095-026-04028-0.

MLA (9th ed.) Citation

Z, Hu, et al. "Population Pharmacokinetic/Pharmacodynamic Modeling of Volagidemab, a Glucagon Receptor Antagonist, in Healthy Chinese and US Subjects Following Single Subcutaneous Administration." Pharmaceutical Research, vol. 43, no. 4, 2026, p. 1057, https://doi.org/10.1007/s11095-026-04028-0.